For research use only. Not for therapeutic Use.
Norfloxacin(Cat No.:A000238)is a broad-spectrum fluoroquinolone antibiotic used to treat bacterial infections, particularly urinary tract infections (UTIs), gastrointestinal infections, and prostatitis. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication and repair, leading to bacterial cell death. With its potent activity against both Gram-positive and Gram-negative bacteria, Norfloxacin is effective in managing a wide range of infections. It is typically administered orally and is available in tablet form for convenient use in outpatient settings. Caution is advised in patients with renal impairment.
Catalog Number | A000238 |
CAS Number | 70458-96-7 |
Synonyms | MK-0366; 70458-96-7; Norfloxacine; Noroxin; Chibroxin; Baccidal |
Molecular Formula | C16H18FN3O3 |
Purity | ≥95% |
Target | Antibiotic |
Solubility | Limited solubility |
Storage | -20°C |
IUPAC Name | 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid |
InChI | InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23) |
InChIKey | OGJPXUAPXNRGGI-UHFFFAOYSA-N |
SMILES | CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O |
Reference | 1: Li H, Chen J, Hou H, Pan H, Ma X, Yang J, Wang L, Crittenden JC. Sustained 2: Ma X, Cheng Y, Ge Y, Wu H, Li Q, Gao N, Deng J. Ultrasound-enhanced nanosized 3: Sidhu GS, Go A, Attar BM, Mutneja HR, Arora S, Patel SA. Rifaximin versus <br> 5: Gómez-Hurtado I, Gimenez P, García I, Zapater P, Francés R, González-Navajas 6: Vignoli Muniz GS, Incio JL, Alves OC, Krambrock K, Teixeira LR, Louro SRW. 7: Piplani M, Rajak H, Sharma PC. Synthesis and characterization of N-Mannich <br> 9: Marín P, García-Martínez F, Hernándis V, Escudero E. Pharmacokinetics of 10: Dave V, Kushwaha K, Yadav RB, Agrawal U. Hybrid nanoparticles for the topical |